cefotiam has been researched along with Gonorrhea in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, HJ; Schim van der Loeff, MF; van Dam, AP; van der Helm, JJ | 1 |
| Korting, HC | 1 |
| Korting, HC; Niederauer, H; Ollert, M | 1 |
| Korting, HC; Neubert, U | 1 |
4 other study(ies) available for cefotiam and Gonorrhea
| Article | Year |
|---|---|
Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, the Netherlands.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefotiam; Creutzfeldt-Jakob Syndrome; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Gonorrhea; Homosexuality, Male; Humans; Incidence; Male; Middle Aged; Neisseria gonorrhoeae; Netherlands; Population Surveillance; Risk Assessment; Risk Factors; Young Adult | 2009 |
Plasma and skin blister fluid levels of cefotiam and cefmenoxime after single intramuscular application of 1 g in gonorrhea.
Topics: Adult; Blister; Cantharidin; Cefmenoxime; Cefotaxime; Cefotiam; Female; Gonorrhea; Humans; Injections, Intramuscular; Kinetics; Male; Suction | 1984 |
High concentrations of antibiotic obtained for a short time excel more long-standing lower levels in the therapy of gonorrhoea. Implications of an in vitro model.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefotiam; Ceftizoxime; Dose-Response Relationship, Drug; Gonorrhea; Humans | 1988 |
Treatment of gonorrhoea with cefotiam: activity in vitro and clinical results of a 1-gram single-dose regimen.
Topics: Cefotaxime; Cefotiam; Female; Gonorrhea; Humans; Injections, Intramuscular; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1985 |